BRAF and cancer: On the other hand, CMS1 cancers, which possessed the highest prevalence of BRAF mutations, presented a downregulated expression of claudin 4 mRNA, independently of the presence or absence of BRAF mutations (two-tailed t test p > 0.05, Figure 5, right).